Javascript är inaktiverat

Javascript verkar vara inaktiverat. Detta kommer att påverka sitens funktionalitet. Vänligen aktivera JavaScript eller återvänd till denna webbplats från en annan enhet.

 

 

Årets Nanna Svartz-föreläsare är Tore K. Kvien!

Prof. em. Tore K. Kvien

Division of rheumatology and research, Diakonhjemmet Hospital, Oslo, Norway and Faculty of Medicine, University of Oslo

Tore K. Kvien has been Professor of Rheumatology at the University of Oslo since 1997 and Head of the Department of Rheumatology at Diakonhjemmet Hospital, Oslo from 1994 to 2019. He is from 2020 professor emeritus at the University and has currently a part time position as senior researcher and research advisor in the hospital. His current major research activities include epidemiological and health service research, as well as therapeutic strategy trials with a focus on frequently occurring diseases such as rheumatoid arthritis, osteoarthritis, and spondyloarthritis. Special focus is also directed on comorbidities, for example cardiovascular morbidity.
Professor Kvien initiated a collaborative project in Norway on very early arthritis, is the leader of the Norwegian NOR-DMARD registry, an observational study of prescriptions of DMARDs and biological agents in Norway and was the principal investigator of the Norwegian government funded NOR-SWITCH trial which was published in Lancet 2017. He has published more than 600 original research articles in international peer-reviewed journals, was President of the European League Against Rheumatism (EULAR) from 2005 to 2007 and was the Editor-in-Chief of the world-leading rheumatology journal for original research – Annals of the Rheumatic Diseases – from 2008 to 2017.
Professor Kvien was recognized as Master of the American College of Rheumatology in 2015, and is honorary member of the Norwegian, Finnish, and Czech rheumatological societies as well as the Norwegian Rheumatism Association. He also received the EULAR meritorious service award in 2017, the Carol Nachman medal in 2018 for his contributions to international rheumatology, and the Norwegian King in 2019 appointed professor Kvien as Officer First Class of the Royal Order of St Olav.